The latest trading session saw Bristol Myers Squibb (BMY) ending at $49.80, denoting a -0.32% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily loss of 0.3%.

The most recent trading session ended with Bristol Myers Squibb (BMY) standing at $52.20, reflecting a -0.38% shift from the previouse trading day's closing. This change lagged the S&P 500's daily ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Bristol Myers Squibb said late Tuesday its new schizophrenia medicine had failed in a late-stage trial, raising new questions about the company’s long-term prospects. U.S. patents protecting some of ...